Research ArticleCLINICAL INVESTIGATIONS
18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients
Esther G.C. Troost, Wouter V. Vogel, Matthias A.W. Merkx, Piet J. Slootweg, Henri A.M. Marres, Wenny J.M. Peeters, Johan Bussink, Albert J. van der Kogel, Wim J.G. Oyen and Johannes H.A.M. Kaanders
Journal of Nuclear Medicine May 2007, 48 (5) 726-735; DOI: https://doi.org/10.2967/jnumed.106.037473
Esther G.C. Troost
Wouter V. Vogel
Matthias A.W. Merkx
Piet J. Slootweg
Henri A.M. Marres
Wenny J.M. Peeters
Johan Bussink
Albert J. van der Kogel
Wim J.G. Oyen
Johannes H.A.M. Kaanders
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients
Esther G.C. Troost, Wouter V. Vogel, Matthias A.W. Merkx, Piet J. Slootweg, Henri A.M. Marres, Wenny J.M. Peeters, Johan Bussink, Albert J. van der Kogel, Wim J.G. Oyen, Johannes H.A.M. Kaanders
Journal of Nuclear Medicine May 2007, 48 (5) 726-735; DOI: 10.2967/jnumed.106.037473
18F-FLT PET Does Not Discriminate Between Reactive and Metastatic Lymph Nodes in Primary Head and Neck Cancer Patients
Esther G.C. Troost, Wouter V. Vogel, Matthias A.W. Merkx, Piet J. Slootweg, Henri A.M. Marres, Wenny J.M. Peeters, Johan Bussink, Albert J. van der Kogel, Wim J.G. Oyen, Johannes H.A.M. Kaanders
Journal of Nuclear Medicine May 2007, 48 (5) 726-735; DOI: 10.2967/jnumed.106.037473
Related Articles
Cited By...
- 18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial
- Using Radiolabeled 3'-Deoxy-3'-18F-Fluorothymidine with PET to Monitor the Effect of Dexamethasone on Non-Small Cell Lung Cancer
- Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy
- 18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study
- Differential 18F-FDG and 18F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer
- PET Imaging of Proliferation with Pyrimidines
- PET Imaging During Radiotherapy of Head and Neck Cancer
- 3'-Deoxy-3'-18F-Fluorothymidine PET-Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients
- 18F-FDG PET Detects Inflammatory Infiltrates in Spinal Cord Experimental Autoimmune Encephalomyelitis Lesions
- Early identification of antigen-specific immune responses in vivo by [18F]-labeled 3'-fluoro-3'-deoxy-thymidine ([18F]FLT) PET imaging
- Novel Positron Emission Tomography Tracer Distinguishes Normal from Cancerous Cells
- Predictive Value of Initial 18F-FLT Uptake in Patients with Aggressive Non-Hodgkin Lymphoma Receiving R-CHOP Treatment
- Can Evaluation of Targeted Therapy in Oncology Be Improved by Means of 18F-FLT?
- Monitoring Tumor Response to Therapy with 18F-FLT PET
- 18F-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors
- Histopathologic Validation of 3'-Deoxy-3'-18F-Fluorothymidine PET in Squamous Cell Carcinoma of the Oral Cavity
- Innovations in Radiotherapy Planning of Head and Neck Cancers: Role of PET
- Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine (18F-FLT) in Head and Neck Cancer Patients Before and Early After Initiation of Chemoradiation Therapy
- 18F-FDG and 18F-FLT Uptake Early After Cyclophosphamide and mTOR Inhibition in an Experimental Lymphoma Model
- PET Monitoring of Therapy Response in Head and Neck Squamous Cell Carcinoma
- 18F-FDG and 18F-FLT Do Not Discriminate Between Reactive and Metastatic Lymph Nodes in Oral Cancer
- In Vivo Characterization of Proliferation for Discriminating Cancer from Pancreatic Pseudotumors
- Imaging of Cell Proliferation: Status and Prospects